MENU
+Compare
HSCS
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$3.57
Change
-$0.21 (-5.56%)
Capitalization
7.66M

HSCS HeartSciences Inc Forecast, Technical & Fundamental Analysis

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease... Show more

HSCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HSCS with price predictions
Jul 03, 2025

HSCS sees MACD Histogram crosses below signal line

HSCS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 03, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 26 instances where the indicator turned negative. In of the 26 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

HSCS moved below its 50-day moving average on July 03, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSCS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 40 cases where HSCS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 20, 2025. You may want to consider a long position or call options on HSCS as a result. In of 48 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HSCS advanced for three days, in of 117 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 16 cases where HSCS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.843) is normal, around the industry mean (24.504). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (126.582) is also within normal values, averaging (43.111).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HSCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
HSCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

HSCS is expected to report earnings to rise 16.73% to -300 cents per share on July 17

HeartSciences Inc HSCS Stock Earnings Reports
Q2'24
Est.
$-3.00
Q1'25
Beat
by $0.43
Q3'24
Beat
by $1.36
Q1'24
Beat
by $0.03
Q4'23
Missed
by $0.04
The last earnings report on March 13 showed earnings per share of -256 cents, beating the estimate of -300 cents. With 45.55K shares outstanding, the current market capitalization sits at 7.66M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
550 Reserve Street
Phone
+1 737 414-9213
Employees
12
Web
https://www.heartsciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVAL2.890.08
+2.85%
Grupo Aval Acciones Y Valores SA
TRU91.611.45
+1.61%
TransUnion
CLNE2.09N/A
N/A
Clean Energy Fuels Corp
AFBI18.32-0.11
-0.60%
Affinity Bancshares
INHD1.18-0.28
-19.18%
Inno Holdings Inc

HSCS and Stocks

Correlation & Price change

A.I.dvisor tells us that HSCS and BNGO have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSCS and BNGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSCS
1D Price
Change %
HSCS100%
-5.56%
BNGO - HSCS
23%
Poorly correlated
+2.12%
WRBY - HSCS
22%
Poorly correlated
+1.28%
SERA - HSCS
21%
Poorly correlated
+1.63%
MBOT - HSCS
21%
Poorly correlated
+4.00%
IQV - HSCS
21%
Poorly correlated
-0.25%
More